Understanding and Managing Autism Spectrum Disorder in Children

Conditions that Occur Together

For children with ASD, it is not uncommon to have other medical and behavioral conditions, which must be considered in their management. Gastrointestinal difficulties such as constipation, diarrhea, and abdominal pain are common and can make behavioral symptoms worse. Further sleep problems like hypersomnia and restless nights lead to even more complex behavioral patterns. Seizures or epilepsy affect a significant proportion of children with ASD, therefore requiring continuous observation and timely medical intervention.

On the other hand, attention-deficit/hyperactivity disorder (ADHD) is another condition often identified among those patients who are already diagnosed with autism spectrum disorder. This presents itself as inattentiveness, hyperactivity, and impulsivity in a child’s behavior. Behavioral interventions and medications can help improve ADHD symptoms so that the child can develop concentration skills to participate fully in school activities. These disorders may also include anxiety as well as mood disorders such as depressive disorders that complicate further social interactions and daily functioning. Cognitive-behavioral therapy (CBT) has been found useful for these comorbidities, while pharmacological treatments are offered on a need basis.

Interventions Supported by Evidence

The intervention strategies target enhancing the areas of communication, social competence, and behavior and, at the same time, decreasing problem behaviors. One of the most commonly recognized types of intervention is ABA, which entails the act of dividing skills into smaller and easily manageable parts and the use of incentives to encourage the desired behaviors. ABA techniques can be used in any establishment, such as a school or home where the child spends his or her time, or in specific environments created suitable for the child’s needs.

Specifically, children with ASD should have speech therapy included in their treatment plan because they have communication disorders. Speech pathologists assist children in their language development to enhance their communication in the use of words and gestures and maintaining eye contact with others, among others. Fine and gross motor coordination skills, sensory integration, or activities of daily living are obtained through occupational therapy that enhances hand-eye coordination, sorting, and self-care.

Social skills training mainly involves educating children with ASD on how to relate with fellow children and other adults. For instance, group activities, social stories, or role-play may all be beneficial when it comes to the way children with AS understand and relate to others. The instructional programs are unique depending on the mode of learning of the kid and the level of development of such plans being called the Individualized Education Programs (IEP).

Family Support and Involvement

Parent training programs show parents how to implement behavioral interventions, support their child’s development, manage challenging behaviors in the child, and promote consistency of treatment across home and school settings. This makes them more effective in facilitating the intervention process.

There is a need for families to receive information on what they can do to help those living with autism spectrum disorder. Through respite care, professionals take temporary charge of a child with ASD so that their parents can have some time off, deal with other obligations, or just relax, which is essential for their overall health.

Support groups are important as they allow families to meet others facing similar challenges, share experiences, acquire knowledge, and get emotional support, thus reducing stress and isolation associated with bringing up a child with ASD.

Emerging Therapies and Research

The current trends reveal that there is active research being made in a bid to find new interventions for ASD. Many schools have called for special education and intervention programs for children in infancy and toddlers who are at high risk of developing ASD, and there is evidence that this strategy has proven to help boost social communication and play in vital odd stages. As for medicamentous intervention, to date, various studies have been done for the management of central Al’s features or the associated condition. It should be noted that at this time there is no known treatment for ASD, but pharmaceuticals do assist in addressing certain symptoms of desire, hyperactivity, agitation, and anxiety.

Computerized applications such as computer programs and the use of virtual reality are being applied where children suffering from autism spectrum disorder (ASD) are trained in social skills, communication, and learning. These tools offer mutually unique approaches in the contextualization of relaying the training of the relevant skills.

Conclusion

As for the children diagnosed with Autism Spectrum Disorder, or ASD, a model of care that entails identification of the early signs of ASD, multidisciplinary assessment of the child, use of empirically-based treatments for the disorder, and supportive care to the family should be followed. In response to the aforementioned deficits and disparities, it is important to mention that by reducing stress and aggression and meeting other needs, as well as addressing, if not all, family, social, and psychological, if not all, significant aspects of a child’s life by individualizing the child’s developmental and educational curriculum, the possibility of long-term success for a child with ASD can be promoted. Further research and progress in the latter aspects of child development will only augment and enhance the treatment of these children and their families and allow them to reach and live a meaningful life.

References

1. Hyman SL, Levy SE, Myers SM; COUNCIL ON CHILDREN WITH DISABILITIES, SECTION ON DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics. 2020 Jan;145(1):e20193447. doi: 10.1542/peds.2019-3447. Epub 2019 Dec 16. PMID: 31843864.
2. Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019 Oct;144(4):e20192528. doi: 10.1542/peds.2019-2528. Erratum in: Pediatrics. 2020 Mar;145(3):e20193997. doi: 10.1542/peds.2019-3997. PMID: 31570648; PMCID: PMC7067282.
3. Crocker AF, Smith SN. Person-first language: are we practicing what we preach? J Multidiscip Healthc. 2019 Feb 8;12:125-129. doi: 10.2147/JMDH.S140067. PMID: 30799931; PMCID: PMC6371927.
4. Zuckerbrot RA, Cheung A, Jensen PS, Stein REK, Laraque D; GLAD-PC STEERING GROUP. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics. 2018 Mar;141(3):e20174081. doi: 10.1542/peds.2017-4081. PMID: 29483200.
5. Adams RC, Levy SE; COUNCIL ON CHILDREN WITH DISABILITIES. Shared Decision-Making and Children With Disabilities: Pathways to Consensus. Pediatrics. 2017 Jun;139(6):e20170956. doi: 10.1542/peds.2017-0956. PMID: 28562298.
6. Bull MJ, Engle WA; Committee on Injury, Violence, and Poison Prevention and Committee on Fetus and Newborn; American Academy of Pediatrics. Safe transportation of preterm and low birth weight infants at hospital discharge. Pediatrics. 2009 May;123(5):1424-9. doi: 10.1542/peds.2009-0559. PMID: 19403510.
7. Stanley MA, Shepherd N, Duvall N, Jenkinson SB, Jalou HE, Givan DC, Steele GH, Davis C, Bull MJ, Watkins DU, Roper RJ. Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome. Am J Med Genet A. 2019 Feb;179(2):177-182. doi: 10.1002/ajmg.a.11. Epub 2018 Dec 27. PMID: 30588741; PMCID: PMC6349541.
8. Palumbo ML, McDougle CJ. Pharmacotherapy of Down syndrome. Expert Opin Pharmacother. 2018 Dec;19(17):1875-1889. doi: 10.1080/14656566.2018.1529167. Epub 2018 Oct 10. PMID: 30257591.